Centrica PLC has announced that two of its executive directors, Christopher O'Shea and Russell O'Brien, have acquired ordinary shares under the Company's Share Incentive Plan. The shares were acquired through Equiniti Share Plan Trustees Limited, the administrators of the Plan. Each director acquired 108 partnership shares and 22 matching shares at prices of £1.395357 and £1.39066666 per share, respectively, totaling 130 shares each. The transactions took place on 10 July 2024, with the partnership shares acquired on the London Stock Exchange and the matching shares outside a trading venue.

The notifications were made in accordance with Article 19 of the Market Abuse Regulation. The Company's Legal Entity Identifier number is E26EDV109X6EEPBKVH76. Centrica PLC is listed on the London Stock Exchange under the ticker symbol CNA and is registered in England & Wales with number 3033654. The company's registered office is located at Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD.